Tag: Generic

Posted on

FDA okays generic Singulair for asthma treatment – The Capitol Column


The Capitol Column

FDA okays generic Singulair for asthma treatment
The Capitol Column
The FDA announced Friday that it has approved the production of generic versions of Singulair, a drug used for the treatment of asthma and allergies. The patent on Singulair, or montelukast sodium, was held by Merck, and expired on Aug. 3, 2012. The …
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesRTT News
FDA OKs generic SingulairChicago Tribune
Generic Singulair ApprovedWebMD
Globes –MedPage Today
all 37 news articles »

View full post on asthma – Google News

Posted on

FDA Approves Generic Versions Of Singulair To Treat Asthma, Allergies – RTT News


MedPage Today

FDA Approves Generic Versions Of Singulair To Treat Asthma, Allergies
RTT News
(RTTNews) – The U.S. Food and Drug Administration said that on Friday it approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor …
Generic Singulair ApprovedWebMD
FDA OKs generic SingulairChicago Tribune
FDA Greenlights Asthma Drug GenericsMedPage Today
Columbus Dispatch –Huffington Post
all 34 news articles »

View full post on asthma – Google News

Posted on

FDA OKs generic Singulair – Chicago Tribune


MedPage Today

FDA OKs generic Singulair
Chicago Tribune
The Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck & Co.'s best-selling product. The drugmakers, whose …
Generic Singulair ApprovedWebMD
Generic asthma drugs receive FDA approvalColumbus Dispatch
FDA Greenlights Asthma Drug GenericsMedPage Today
FDA.gov –Huffington Post –Babble (blog)
all 33 news articles »

View full post on asthma – Google News

Posted on

Generic Singulair Approved – WebMD


MedPage Today

Generic Singulair Approved
WebMD
3, 2012 — The FDA today gave 10 generic drugmakers approval to start making generic versions of Singulair (montelukast sodium), the popular asthma and allergy drug. Singulair, usually taken in the form of tablets, has been a blockbuster drug for Merck.
FDA Greenlights Asthma Drug GenericsMedPage Today
Generic Singulair: Cheaper Forms Of Asthma, Allergy Medication Approved By …Huffington Post
HOT DAMN: Expensive Asthma/Allergy Medication Singulair Goes GenericBabble (blog)
FDA.gov –U.S. News & World Report
all 21 news articles »

View full post on asthma – Google News

Posted on

Watson gets FDA approval for generic asthma drug – Businessweek

Watson gets FDA approval for generic asthma drug
Businessweek
PARSIPPANY, N.J. (AP) — Generic drugmaker Watson Pharmaceuticals Inc. said Wednesday it received U.S. approval for its generic version of Pulmicort, an inhalable drug used to treat cough and breathing problems caused by asthma and lung disease.
FDA approves Watson asthma genericDrug Store News
Watson's Generic Version of Pulmicort RESPULES® Receives FDA ApprovalMarketWatch (press release)

all 13 news articles »

View full post on asthma – Google News

Posted on

Mylan to challenge court decision over generic asthma, COPD drug – Drug Store News

Mylan to challenge court decision over generic asthma, COPD drug
Drug Store News
… in the US District Court for the District of Delaware when the latter sought to market a generic version of Sunovion's Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease.
Mylan to fight $18M patent infringement rulingPittsburgh Business Times

all 4 news articles »

View full post on asthma – Google News

Posted on

Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion … – BioMedReports (subscription)

Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion …
BioMedReports (subscription)
The overall asthma drug market will decrease slightly from $14.6 billion in 2010 to $14.4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. “Driving these sales will be the uptake of emerging once-daily …
Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion …MarketWatch (press release)

all 17 news articles »

View full post on asthma – Google News

Posted on

Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion … – MarketWatch (press release)

Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion …
MarketWatch (press release)
The overall asthma drug market will decrease slightly from $14.6 billion in 2010 to $14.4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The Pharmacor advisory service entitled Asthma finds that the …

and more »

View full post on asthma – Google News

Posted on

Nycomed and Orion to sell generic Advair and Symbicort – Pharma Times

Nycomed and Orion to sell generic Advair and Symbicort
Pharma Times
The firms have signed an agreement which covers Orion's combination products for the treatment of asthma and chronic obstructive pulmonary disease, delivered by its new Easyhaler dry powder inhaler. In particular, Orion is developing copies of GSK's …
Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPDReuters (press release)

all 6 news articles »

View full post on asthma – Google News

Posted on

Generic medication could make diabetes, blood pressure, asthma treatments more … – Today’s THV

Generic medication could make diabetes, blood pressure, asthma treatments more …
Today’s THV
Generic competition of best selling drugs for blood pressure, asthma and diabetes will slash the cost to patients. Doctors hope the lower prices will benefit people jeopardizing their health because they can't afford medications. …

and more »

View full post on asthma – Google News